Fiserv (FI) stock was the top decliner in the S&P 500 index on Thursday after its Chief Financial Officer Bob Hau said second-quarter volume growth at its point-of-sales platform, Clover, would remain at similar levels as the first quarter.

Speaking at the J.P. Morgan Global Technology, Media and Communications Conference, Hau said the company expects increased challenges at its payment gateway, which led to a 16.2% fall in its share prices.

“We expect the second quarter to be generally similar to the first quarter in terms of the reported growth rate from a volume standpoint,” Hau said about Clover.

Read Next

Bitcoin Climbs Within 1% Of Record High Amid US Government Shutdown Uncertainty

Prabhjote Gill·6h ago

In the first quarter, Fiserv’s volume growth at Clover slowed to 8% from 14% during the fourth quarter.

Hau pointed out several reasons behind the decline, with the previous year being a leap year and a decline at its largest international market, Canada.

According to TheFly, Mizuho lowered the price target for the stock to $200 from $220. The brokerage said Clover's revenue growth of 27% is "still impressive despite only" 8% volume growth.

Baird analysts said that while the lack of Q2 reported volume growth acceleration is "concerning," the stock move "seems overblown."

The brokerage did not see many changes to Fiserv's total financial picture and pointed out that Hau had reiterated the company’s forecast.

“We remain confident in delivering on our goal of $3.5 billion of revenue by the end of the year," Hau said at the conference, noting strong hardware sales and improved activity in the second half.

Retail sentiment on Stocktwits was in the ‘extremely bullish’ (84/100) territory, while retail message volume surged more than 6000%.

One user said the stock is slated for a rebound as the premium is gone.

TraderdoggyMay 15, 2025 7:45 PM

$FI In for a rebound trade. Stock was premium priced in many ways but that's gone now it seems. Listened to the first part of call today and yeah not perfect but stock reaction seems harsh esp following q1.

2

“Fiserv’s inability to accelerate Clover’s volume growth suggests it may be losing ground to more agile fintech rivals offering better features or pricing,” another user said.

spirituallyconsistenttpMay 15, 2025 10:23 PM

$FI Clover Growth Slowdown: The Clover platform, a critical growth driver, has underperformed expectations. Despite a reported 27% revenue growth in Q1 2025, volume growth was weaker than anticipated, and the CFO’s comments at the JPMorgan Global Technology Conference today confirmed no improvement in Q2. This contrasts with competitors like Square (Block, Inc.), which has consistently posted stronger growth in its point-of-sale ecosystem, with 2024 gross payment volume growth around 10-15% year-over-year. Fiserv’s inability to accelerate Clover’s volume growth suggests it may be losing ground to more agile fintech rivals offering better features or pricing. Square lost 50% of its value recently, despite showing better metrics than Fiserv IMHO. This is technically untouchable for a long time to come this year. Stay Safe! Bearish

Show More

Fiserv stock has fallen 23.1% year to date (YTD).

Also See: Shoals Stock Tumbles After BNP Paribas Downgrades On Nextracker Challenge, Retail Bulls Hold Ground

For updates and corrections, email newsroom[at]stocktwits[dot]com.

Share

·

Add us on

Travere Therapeutics shares tumbled over 15% in extended trading Thursday after the company said the U.S. Food and Drug Administration will convene an advisory committee meeting to review a supplemental use of its kidney drug, Filspari.

The FDA accepted Travere's supplemental New Drug Application (sNDA) seeking traditional approval of Filspari for the treatment of focal segmental glomerulosclerosis (FSGS), a rare and serious kidney disorder with no FDA-approved therapies. 

Under the Prescription Drug User Fee Act, the agency has now set a target action date of Jan. 13, 2026.

Read Next

Bitcoin Climbs Within 1% Of Record High Amid US Government Shutdown Uncertainty

Prabhjote Gill·6h ago

"We are one step closer to potentially delivering the first approved treatment for people living with FSGS - a leading cause of kidney failure and devastating condition that urgently needs new treatment options," said CEO Eric Dube.

While the advisory committee (AdComm) meeting introduces an added review step, it is a standard part of the FDA's drug approval process and not necessarily a red flag. However, negative recommendations from such meetings can lead to delays or rejections.

Despite the market reaction, sentiment on Stocktwits ended 'extremely bullish' on Thursday, with message volume jumping from 'normal' to 'high.' Some retail traders saw the selloff as overdone.

"Oversold now.  It's an ADCOM, and by no means a bad thing when a meeting is required. It boils down to a safe and highly needed prescription drug, that just needs to thread the needle of the FDA," one user wrote.

FloatTripMay 16, 2025 12:11 AM

$TVTX Worked all day, so I missed this. OK,.. there it is. Heavy sell at that price. Oversold now. It's an ADCOM, and by no means a bad thing when a meeting is required. It boils down to a safe and highly needed prescription drug, that just needs to thread the needle of the FDA.

3

"From late fall to just January 2026, is not that big of a deal to wait to get the "T's" crossed and the "I's" dotted. A few months added from the original timeframe," another said, brushing off the timeline shift.

FloatTripMay 15, 2025 11:37 PM

$TVTX From late Fall to just January 2026, is not that big of a deal to wait to get the "T's" crossed and the "I's" dotted. A few months added from the original timeframe....Meh.....

3

However, investors often cheer when the FDA skips an AdComm — as seen in March, when Tonix Pharma stock surged on news its fibromyalgia drug would not require such a review.

Filspari is already approved to slow kidney function decline in IgA nephropathy, another rare kidney condition. FSGS affects more than 40,000 patients in the U.S., and Travere is seeking to expand Filspari's label for this population.

Travere shares are up over 19% year to date, but short interest has climbed, rising from 8.5% at the start of 2025 to 11.9% as of last week, according to Koyfin.

For updates and corrections, email newsroom[at]stocktwits[dot]com.

Share

·

Add us on

Shares of Jubilant FoodWorks, the Domino's Pizza franchisee, faces potential decline below the ₹600 level due to weakening momentum, according to SEBI-registered analyst Kush Ghodasara.

Edge

KushghodasaraMay 15, 2025 9:24 AM

SEBI Research Analyst

$JUBLFOOD.NSE - Pizza base yet not baked Completely Stock has been consolidating over 200 day average at 634 since the March expiry but the momentum is not that strong as it should be because price has been trading below 10-15 day average since a week. On the other side, RSI has given a negative crossover internally and is headed south while MACD is about to crossover 0 line too. To Sum up, though stock is trading above 200 day average but the move is not convincing and therefore we should avoid ordering some PIZZA. On the downside, we could test sub 600 levels with stop loss on upside at 700. Bearish

7

According to Ghodasara, the stock has remained close to ₹634, which represents its 200-day moving average, since the March expiry. 

Read Next

Bitcoin Climbs Within 1% Of Record High Amid US Government Shutdown Uncertainty

Prabhjote Gill·6h ago

At the time of writing, shares of Jubilant FoodWorks were down 1.2% at ₹675.75.

He said that the stock's momentum remains unconvincing because its price has not recovered above the 10- and 15-day moving averages for more than seven days.

The relative strength index (RSI) indicator has moved into negative territory and shows a downward trend while the moving average convergence divergence (MACD) approaches the zero line from above. 

Both indicators suggest further downside pressure, Ghodasara said. 

Considering the technical indicators, Ghodasara warned against new investments and predicted the stock to reach below ₹600. He recommended setting a stop loss at ₹700.

The weak technicals come after a 76.86% decline in its fourth-quarter (Q4) net profit. 

Jubilant FoodWorks reported ₹48 crore in net profit, a decrease from the previous year's ₹207.5 crore.

The decline came despite a 33.6% increase in revenue reaching ₹2,103 crore, thanks to robust QSR demand and both new store launches and menu innovations.

On Stocktwits, retail sentiment was ‘bearish’ amid ‘high’ message volume.

The stock has fallen 8.6% so far in 2025.

For updates and corrections, email newsroom[at]stocktwits[dot]com.

Share

·

Add us on

TSS, Inc. (TSSI) shares soared in Thursday’s post-market session after the Round Rock, Texas-based company announced sharp increases in quarterly profits and revenue. The company also issued positive commentary for the remainder of the year.

The IT services company reported earnings per share (EPS) of $0.12 for the first quarter of the fiscal year 2025, compared to breakeven results a year ago and $0.08 reported for the preceding quarter.

The company designs, deploys, equips, and manages data centers and other technology environments for enterprise companies, colocation providers, and technology company partners.

Read Next

Bitcoin Climbs Within 1% Of Record High Amid US Government Shutdown Uncertainty

Prabhjote Gill·6h ago

Revenue climbed 523% year-over-year to $99 million, with the sequential growth at 98%. The company noted that procurement services revenue, making up over 90% of the total revenue, climbed 676%.

Adjusted earnings before interest, taxes, and depreciation (EBITDA) improved to $5.2 billion from the year-ago’s $475,000.

Darryll Dewan, CEO of TSS, said, “We are off to a strong start in 2025, with exponential increases in both our top and bottom lines, driven by robust growth in our Procurement and Systems Integration segments, including incremental contribution from AI rack integration services.”

The CEO said the company began initial production at its new facility last week. He added that he expects production volumes to grow in the second quarter and continue to ramp throughout the remainder of 2025 and into 2026.

“Based on our current visibility, and within the ever-changing geopolitical environment, we continue to expect total revenue in the first half of 2025 to exceed total revenue in the second half of 2024,” he added.

The company also said it expects full-year 2025 adjusted EBITDA to be at least 50% higher than 2024.

On Stocktwits, sentiment toward TSS stock was ‘extremely bullish’ (95/100) by late Thursday, with the message volume at an ‘extremely high’ level.

The stock was among the top ten trending tickers on the platform early Friday.

A bullish user called the earnings' stellar' and hoped for the stock to hit a new all-time high.

yongjinoveMay 16, 2025 3:44 AM

$TSSI stellar earnings here, rooting for all shareholders 👍 - hopefully a new ATH! Bullish

13

Another user commended the company on the earnings beat but said they would look for only day or swing trading opportunities.

Bagstand204May 16, 2025 3:09 AM

$TSSI Nice beat! On watch tomorrow for dips if theres decent volume. Wont be a long term hold just a day trade or potential shorter term swing. Bullish

1

1

6

The TSS stock jumped 51.07% in Thursday’s after-hours trading but is down about 25% for the year.

For updates and corrections, email newsroom[at]stocktwits[dot]com.

Read Next: ‘Big Short’ Fame Michael Burry Makes Bearish Bets On Nvidia, Chinese Stocks — But Increases Exposure To This Consumer Stock

Share

·

Add us on

Cochin Shipyard has caught the market’s eye with a remarkable 38% rally in just one week, on the back of strong volumes and renewed investor interest. 

The defense PSU racked up another 10% gain on Friday as investors cheered its steady fourth quarter earnings.

The surge aligns with bullish sentiment across India’s defense and shipbuilding sector, buoyed by government policy support and increasing strategic focus on indigenous naval capability.

Read Next

Bitcoin Climbs Within 1% Of Record High Amid US Government Shutdown Uncertainty

Prabhjote Gill·6h ago

From a technical standpoint, the momentum appears far from over. 

SEBI-registered analyst Manish Kushwaha notes a strong technical recovery after a recent correction, with the stock bouncing off the 61.8% Fibonacci retracement level and decisively breaking out above a key downtrend resistance line. 

The emergence of a bullish weekly candle further supports the view of a potential trend reversal, with current prices hovering near the 38.2% retracement zone. 

He believes that a sustained close above this level may trigger the next leg of upside, possibly retesting the ₹2,900 mark.

Kushwaha also highlights a surge in trading volumes, indicating accumulation by market participants, while the Relative Strength Index (RSI) at 62.16 reflects continued bullish momentum without entering overbought territory. 

The medium-term outlook remains optimistic, with a recommended buy range of ₹1,820–₹1,825, targets at ₹2,480, ₹2,900, and ₹3,500, and a stop-loss at ₹1,490.

The stock’s recent price action — breaking past resistance near ₹1,800 — reinforces this view. 

If Cochin Shipyard manages a sustained weekly close above this range, supported by volumes, it could confirm a strong base for a renewed rally.

Edge

Wealthwise_researchMay 15, 2025 9:15 AM

SEBI Research Analyst

Weekly Chart 📈 Analysis Script Name: Cochin Shipyard Action: Buy Trade Duration: Medium Term ( 15 Days to 3 Months) CMP: 1780 Range: 1820-1825 Targetthe : 1st 2480, 2nd 2900, 3rd 3500 Stop Loss: 1490 Stock has made a strong recovery after a correction, receiving support from the 61.8% retracement level and breaking out from a downtrend resistance line. The recent bullish candle indicates robust buying interest, which may confirm a trend reversal. Currently, the price is hovering around the 38.2% retracement level. A sustained close above this level could signal further upside potential. There has been a noticeable increase in trading volume, supporting the bullish breakout. Rising volume on green candles suggests accumulation by market participants. The Relative Strength Index (RSI) at 14 is approximately 62.16, indicating bullish momentum, though it is not yet in the overbought zone. Cochin Shipyard exhibits strong technical indicators for a bullish continuation after a healthy correction. A weekly close above the range of 1770 to 1800, accompanied by strong volume, could initiate the next leg toward the previous high of 2900. $COCHINSHIP.NSE

Show More

2

13

For investors eyeing defense sector plays, this stock stands out not just for its strategic relevance but also for its compelling chart structure and market positioning.

Data on Stocktwits shows that retail sentiment is ‘extremely bullish’ on this counter. 

Cochin Shipyard shares have gained 30% year-to-date (YTD).

For updates and corrections, email newsroom[at]stocktwits[dot]com.

Share

·

Add us on

A day after the Nifty 50 staged a strong breakout above 25,000, Indian equity benchmarks opened on a cautious note Friday, as traders booked profits and digested recent gains. 

Despite the mild weakness, the Nifty held above the key psychological level of 25,000 in early trade.

By 9:45 a.m. IST, the Nifty 50 was down 25 points at 25,036, while the Sensex slipped 173 points to 82,356.

Read Next

Bitcoin Climbs Within 1% Of Record High Amid US Government Shutdown Uncertainty

Prabhjote Gill·6h ago

Broader markets continued their outperformance streak, with the Nifty Smallcap index logging gains for the fifth consecutive session. 

The Midcap index added 0.5%, reflecting sustained investor interest in secondary market names even as frontline indices took a breather. 

Sectorally, autos, real estate, and defense stocks saw fresh buying, while IT and pharma shares faced some pressure. 

Meanwhile, retail sentiment on Stocktwits for the Nifty 50 is ‘neutral’.

Among key stock movers, IndusInd Bank fell 2% after  the disclosure of further accounting errors. An internal audit revealed ₹674 crore in overstated interest income across three quarters of FY25, reigniting concerns around transparency. 

Crompton Greaves surged 5% following strong Q4 earnings, with Nomura assigning a 36% upside on growth driven by new launches and categories. 

PB Fintech gained 2% after posting a net profit that more than doubled year-on-year, beating street expectations.

On the downside, Bharti Airtel dropped 3% after 3.1 crore shares changed hands in a block deal, reportedly involving a stake sale by a Singtel subsidiary. 

JSW Infrastructure also declined 2% on reports that Sajjan Jindal Family Trust was trimming its holding via a similar transaction.

Investors will monitor BHEL, Texmaco, Hyundai Motor, Delhivery, Emami as they report quarterly numbers later in the day. 

SEBI-registered advisors shared the day's trade setup on Stocktwits.

From a technical standpoint, SEBI-registered analyst Ashish Kyal flagged 25,120 as a key intraday resistance level. 

A decisive break above this could open the door to 25,300, in line with current bullish momentum in the broader market. 

Kyal identified 24,800 as the immediate support and advises positional traders to maintain trailing stop-losses as long as the index does not close below its previous swing low.

Edge

kyalashishMay 16, 2025 3:29 AM

SEBI Research Analyst

$NIFTY50.NSE is moving precisely as per price time symmetry, break above 25120 to take prices to 25300, immediate support is at 24800 levels, positional traders should follow trailing stop and keep riding unless close below prior low, follow this trend following method & see the magic!

1

4

A&Y Market Research sees intraday Nifty resistance between 25,187–25,238 and support in the 24,746–24,811 range. 

For Bank Nifty, resistance lies at 55,443–55,557, with support seen at 54,334–54,470.

Edge

aymr_sebi_raMay 16, 2025 3:35 AM

SEBI Research Analyst

$NIFTY50.NSE $NIFTYBANK.NSE Nifty (Intraday) Resistance : 25,187 - 25,238 Support : 24,746 - 24,811 Bank Nifty (Intraday) Resistance : 55,443 - 55,557 Support : 54,334 - 54,470 Disclaimer: This update is for informational purposes only and should not be considered as investment advice. Please conduct your own research before making any financial decisions

1

1

3

Asian markets traded mixed and U.S. stock futures were seen subdued. 

For updates and corrections, email newsroom[at]stocktwits[dot]com.

Share

·

Add us on